Delivery Order SPE2DB20D2014-SPE2DB24FC04Q

Award Date 5/28/24
Potential Completion Date 5/29/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,127.36 firm fixed-price delivery order is for the supply of 4,567,461,943 units of Pantoprazole Sodium Delayed-Release 40 mg tablets, a medication used for the treatment of various gastrointestinal conditions. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,732,472 units of pantoprazole sodium delayed-release 40 mg tablets, with a ceiling value of $1,670.76. The contract is a firm-fixed price delivery order with a period of performance through March 31, 2025. This award is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award, valued at $5,637.03, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of 4,564,977,390 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a completion date of June 24, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical to...
This federal contract award is for the delivery of 450 tablets of Pantoprazole Sodium Delayed-Release 40 mg, a prescription medication. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables efficient...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,554,560,733 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000 count bottles. The $5,544.87 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,372.66 firm fixed-price delivery order contract is for the supply of 4,565,377,081 units of pantoprazole sodium delayed-release 40 mg tablets. The award has an ultimate completion date of August 8, 2024 and was not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,038.98 Firm Fixed Price Delivery Order is for the supply of 4,563,401,913 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of January 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $6,332.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,584,798 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets, in 1,000-count bottles. The contract is a Firm Fixed Price Delivery Order, with a period of performance through March 17, 2025. There is no set-aside designation for this award....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets in 1,000-count bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $7,495.89, and has an ultimate completion date of September 12, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, will provide these...
This federal contract award is for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg Tablets, in a quantity of 1,000 tablets, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,473.51 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC04Q
    Delivery Order

This federal contract award is for the delivery of 4,564,731,258 units of pantoprazole sodium delayed-release 40 mg tablets in 1,000 count sizes. The contract was awarded to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,833.54. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, the company holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 8/27/24, 9:30 AM